Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical practice, and plays an essential role in preoperative systemic evaluation and tumor staging in various cancer patients. With this method, it is possible to measure or compare metabolic changes in cancer cells. With combined PET/CT, it is possible to determine the correct anatomical location in hypermetabolic tumors with uptake of FDG. In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT

___

  • 1. Sachpekidis, C., Exadaktylou, P., Katsampoukas, D., Moralidis, E., & Arsos, G. (2020). 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine, 23(1), 76–78. https://doi.org/10.1967/s002449912006
  • 2. Zeng, W., Lechowicz, M. J., Winton, E., Cho, S. M., Galt, J. R., & Halkar, R. (2009). Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine, 34(6), 355–358. https://doi.org/10.1097/RLU.0b013e3181a34552
  • 3. Wang, X., Chen, Z., Tang, G., & Zhang, X. (2011). A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT. Clinical nuclear medicine, 36(7), 612–615. https://doi.org/10.1097/RLU.0b013e318217af84

___

Bibtex @olgu sunumu { moi1257581, journal = {Molecular Oncologic Imaging}, eissn = {2791-965X}, address = {Mersin Üniversitesi Çiftlikköy Kampüsü Tıp Fakültesi}, publisher = {Mersin Üniversitesi}, year = {2022}, volume = {2}, number = {2}, pages = {25 - 26}, title = {Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma}, key = {cite}, author = {Yavan, Gökçe and Koç, Zehra Pınar and Özcan, Pınar Pelin} }
APA Yavan, G. , Koç, Z. P. & Özcan, P. P. (2022). Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma . Molecular Oncologic Imaging , 2 (2) , 25-26 .
MLA Yavan, G. , Koç, Z. P. , Özcan, P. P. "Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma" . Molecular Oncologic Imaging 2 (2022 ): 25-26 <
Chicago Yavan, G. , Koç, Z. P. , Özcan, P. P. "Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma". Molecular Oncologic Imaging 2 (2022 ): 25-26
RIS TY - JOUR T1 - Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma AU - GökçeYavan, Zehra PınarKoç, Pınar PelinÖzcan Y1 - 2022 PY - 2022 N1 - DO - T2 - Molecular Oncologic Imaging JF - Journal JO - JOR SP - 25 EP - 26 VL - 2 IS - 2 SN - -2791-965X M3 - UR - Y2 - 2022 ER -
EndNote %0 Molecular Oncologic Imaging Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma %A Gökçe Yavan , Zehra Pınar Koç , Pınar Pelin Özcan %T Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma %D 2022 %J Molecular Oncologic Imaging %P -2791-965X %V 2 %N 2 %R %U
ISNAD Yavan, Gökçe , Koç, Zehra Pınar , Özcan, Pınar Pelin . "Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma". Molecular Oncologic Imaging 2 / 2 (Ağustos 2022): 25-26 .
AMA Yavan G. , Koç Z. P. , Özcan P. P. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022; 2(2): 25-26.
Vancouver Yavan G. , Koç Z. P. , Özcan P. P. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022; 2(2): 25-26.
IEEE G. Yavan , Z. P. Koç ve P. P. Özcan , "Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma", , c. 2, sayı. 2, ss. 25-26, Ağu. 2022